Innovation to Impact Grants Competition Results

We are pleased to announce the results of the most recent Innovation to Impact  Grants competition to support unique and creative research ideas that will impact cancer.

We are pleased to announce the results of the most recent Innovation to Impact Grants competition to support the further development of successful findings based on the goals originally explored through a CCS Innovation Grant or eligible CBCF grant. Below is a listing of newly awarded Innovation to Impact Grants.

Out of a total of 57 grant applications reviewed, 15 Canadian Cancer Society Innovation to Impact Grants have been approved – a 26% success rate. Funds committed to this competition have been made possible by the significant efforts of CCS donors and volunteers across the country. These projects total more than $6.5 million in funding over the full term of these grants.

    Please note: 
  • Amounts listed below represent the total dollars awarded by grant year and may include funds for salaries, supplies, and/or equipment.
  • The start date for these grants is August 1, 2018.
  • Only the Principal Investigator is named in this listing. Co-Principal Investigators, Co-Applicants and/or Additional Authors may also be associated with these grants.

Note Carefully:

Although every effort has been made to ensure the accuracy of the listing below, this list does not constitute an "official" notification.

Successful applicants will be informed, in writing, with an official Notification of Award giving the details pertaining to their grant.

Project title


Brooks-Wilson, Angela
BC Cancer Agency (Vancouver)
Genetic buffering in cancer
2018/2019  $127,000
2019/2020  $127,000
2020/2021  $127,000
Karsan, Aly
BC Cancer Agency (Vancouver)
Mechanisms of resistance to 5-Azacytidine
2018/2019  $150,000
2019/2020  $150,000
2020/2021  $150,000
Gingras, Anne-Claude
Mount Sinai Hospital
Endocytic organelles as sites of cellular growth control
2018/2019  $149,999
2019/2020  $149,999
2020/2021  $149,999
Kislinger, Thomas
Princess Margaret Cancer Centre - UHN
Molecular analyses of the protocadherin fat 2: a novel therapeutic target in head and neck cancers
2018/2019 $150,000
2019/2020 $150,000
2020/2021 $150,000
Pratt, Christine
University of Ottawa
Role of the DNA damage response in promotion of BRCA2 breast cancer
2018/2019 $149,440
2019/2020 $149,440
2020/2021 $149,440
Stirling, Peter
BC Cancer Agency (Vancouver)
Exploiting R-loop associated genome instability in high grade serous ovarian cancer
2018/2019 $150,000
2019/2020 $150,000
2020/2021 $150,000
Duzenli, Cheryl
BC Cancer Agency (Vancouver)
Reducing toxicity in whole breast adjuvant radiotherapy using a novel breast positioning device
2018/2019  $120,752
2019/2020  $111,474
2020/2021  $113,299
Hirasawa, Kensuke (Ken)
Memorial University
Improving photodynamic diagnosis and therapy by targeting the MEK-ABCB1 axis
2018/2019 $150,000
2019/2020 $150,000
2020/2021 $150,000
Martel, Anne
Sunnybrook Research Institute
Quantitative assessment of tumour burden in breast cancer
2018/2019  $149,867
2019//2020 $149,969
2020/2021  $149,969
Schaffer, Paul
University of British Columbia
Pursuit of a clinical application for direct, aqueous, F-18 photo-fluorination of amino acids and peptides
2018/2019 $138,236
2019/2020 $147,566
2020/2021 $149,537
Nelson, Brad
BC Cancer Agency (Victoria)
The interface of malignant and immunologic clonal dynamics in high grade serous ovarian cancer: towards actionable immunotherapy strategies
2018/2019 $149,995
2019/2020 $149,995
2020/2021 $149,995
Reedijk, Michael
Princess Margaret Cancer Centre - UHN
Targeting USP9x to inhibit Notch in triple-negative breast cancer
2018/2019 $148,719
2019/2020 $150,000
2020/2021 $150,000
McGill University
Deciphering mechanisms that control focal adhesion dynamics and invadopodia formation in metastatic breast cancer
2018/2019 $150,000
2019/2020 $150,000
2020/2021 $150,000
Zuniga-Pflucker, Juan Carlos
Sunnybrook Research Institute
A simple and effective approach to generate T cells for immune-regeneration
2018/2019 $150,000
2019/2020 $150,000
2020/2021 $150,000
Ringash, Jolie
Princess Margaret Cancer Centre - UHN
Efficacy of the rehabilitation planning consult for survivors of head and neck cancer: a phase II randomized controlled trial
2018/2019 $150,000
2019/2020 $150,000
2020/2021 $150,000